home / stock / cyrx / cyrx news


CYRX News and Press, CryoPort Inc. From 07/28/23

Stock Information

Company Name: CryoPort Inc.
Stock Symbol: CYRX
Market: NASDAQ
Website: cryoport.com

Menu

CYRX CYRX Quote CYRX Short CYRX News CYRX Articles CYRX Message Board
Get CYRX Alerts

News, Short Squeeze, Breakout and More Instantly...

CYRX - Headwaters Capital Q2 2023 Investor Letter

2023-07-28 09:00:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The portfolio gained +17.4% (17.2% net) for the second quarter of 2023 compared to a +4.8% return for the Russell M...

CYRX - Cryoport: Revising To Hold After Major Changes To Forecasts, Sentiment

2023-07-14 09:05:33 ET Summary Cryoport released preliminary Q2 results, projecting sales to fall behind The Street's estimates. Lower demand for Cryoport's capital equipment and delays in initiating clinical trials are key reasons behind the changes. Management remains optimi...

CYRX - RMTI, CYRX and TMC among pre-market losers

2023-07-14 08:15:40 ET First Wave BioPharma ( FWBI ) -32% . Healthcare Triangle ( HCTI ) -31% . SunCar Technology Group ( SDA ) -30% . Rockwell Medical ( RMTI ) -30% . Cadrenal Therapeutics ( CVKD ) -30% . Viasat ( VSAT ) -...

CYRX - Why Shares of Cryoport are Tumbling Thursday

2023-07-13 11:17:52 ET Shares of Cryoport (NASDAQ: CYRX) were down more than 24% by 11 a.m. on Thursday after the company announced preliminary second-quarter earnings. The stock is down more than 16% so far this year. Cryoport supplies temperature-controlled supply chain soluti...

CYRX - TGTX, HIMS and CEI among pre-market losers

2023-07-13 08:30:54 ET Ault Alliance ( AULT ) -35% announces a second partial distribution of TOG securities of approximately $0.37 for each share of ault alliance common stock. First Wave BioPharma ( FWBI ) -34% after Phase 2 setback for gut therapy. Cryop...

CYRX - Cryoport stock plunges after Q2 revenue update, cuts FY forecast

2023-07-12 16:31:25 ET Cryoport ( NASDAQ: CYRX ) said Wednesday it expects revenue to be between $56.5 and $57.5 million for the second quarter of 2023. The Seeking Alpha consensus estimate for Q2 revenue is $67.4 million. The results reflect weaker than expected glo...

CYRX - Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations

Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations PR Newswire Second quarter results were impacted by weaker ...

CYRX - Cryoport: A Strong Player In Cold-Chain Logistics With Solid Growth Prospects

2023-07-04 21:42:13 ET Summary Cryoport, Inc. is well-positioned to benefit from the growth in the cell and gene therapy industry due to its dominant position in the cold-chain logistics market and potential for substantial revenue growth. The company's global presence and focus o...

CYRX - IVFAustralia Selects Cryoport as Exclusive Supply Chain Solutions Provider

IVFAustralia Selects Cryoport as Exclusive Supply Chain Solutions Provider PR Newswire SYDNEY and NASHVILLE, Tenn. , June 29, 2023 /PRNewswire/ -- IVFAustralia , an Australian-based provider of full-service fertility care, IVF and related services as par...

CYRX - KTOS and ALPP among industrial movers

2023-06-21 13:26:56 ET Gainers: PureCycle Technologies ( PCT ) +17% . LogicMark ( LGMK ) +14% . Kratos Defense & Security Solutions ( KTOS ) +13% . LanzaTech Global ( LNZA ) +11% . Losers: VCI Global Limited ( VCIG ) -30% ...

Previous 10 Next 10